WebAdvertisers Access Statistics Resources. Dr Mohan Z Mani "Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone … WebBisphosphonates are pharmacological agents used to treat osteoporosis patients. This pharmacological agent is a potential bone resorption inhibitor. So, the use of bisphosphonates can be useful for orthodontist to control anchorage movement. Many literatures have begun to discuss the use of BP in orthodontic treatment patients.
National Center for Biotechnology Information
WebApr 28, 2016 · bisphosphonates and orthodontics clinical implications. Apr. 28, 2016 • 21 likes • 3,044 views Education The Indian Dental Academy is the Leader in continuing dental education , training dentists in all … WebApr 21, 2024 · Bisphosphonates, also known as diphosphonates, are a class of drugs that have been used commonly for more than two decades for the treatment and prevention of osteoporosis. Bisphosphonates slow bone resorption by reducing osteoclast function. teatime latest results
Optimizing orthodontic treatment in patients taking bisphosphonates for ...
WebBisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner. Br Dent J. 2007Review Zahrowski JJ. Bisphosphonate treatment: an orthodontic concern calling for a proactive approach. Am J Orthod Dentofacial Orthop. 2007Review Khosla et al. Bisphosphonate-associated osteonecrosis of the jaw: report … WebDec 22, 2010 · In contrast, experiments involving local administration of bisphosphonates in rats have suggested a potential positive role for topical bisphosphonates in orthodontic treatment, inhibiting undesirable movement of anchor teeth and inhibiting post-treatment relapse in a dose dependent manner. 53, 54 However, extrapolation of these animal … Web1. Bisphosphonates are the most clinically important class of antiresorptive agents available to treat diseases characterized by osteoclast-mediated bone resorption. Currently, seven bisphosphonates have the approval of the United States Food and Drug Administration. The most common adult diseases treated with bisphosphonates include ... teatime 49s latest results